DRREDDY

recalls epilepsy drug in US over mislabeling concerns

's Laboratories recalled one batch (A1540076) of Levetiracetam in 0.75% Sodium Chloride Injection in the US due to a labeling error. The incorrect label could lead to double the intended dose, posing health risks like hypersensitivity and respiratory depression. Distributed from Nov 4-6, 2024, the recall was issued with FDA knowledge; no adverse events reported.